Myung-Ju Ahn, MD, Samsung Medical Center, Korea
ESMO Live Interpretation of Bispecific Antibody Synergistic Mechanisms Provides Breakthrough Strategies to Overcome Drug Resistance, Pioneering New Directions in Personalized Lung Cancer Treatment.
Myung-Ju Ahn, MD, Samsung Medical Center, Korea
ESMO Live Interpretation of Bispecific Antibody Synergistic Mechanisms Provides Breakthrough Strategies to Overcome Drug Resistance, Pioneering New Directions in Personalized Lung Cancer Treatment.